These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2988125)

  • 41. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.
    Khan F; Porter M; Schwenk R; DeBot M; Saudan P; Dutta S
    PLoS One; 2015; 10(11):e0142035. PubMed ID: 26571021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.
    White K; Krzych U; Gordon DM; Porter TG; Richards RL; Alving CR; Deal CD; Hollingdale M; Silverman C; Sylvester DR
    Vaccine; 1993 Oct; 11(13):1341-6. PubMed ID: 7507624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.
    Malik A; Egan JE; Houghten RA; Sadoff JC; Hoffman SL
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3300-4. PubMed ID: 1707538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.
    Persson C; Oliveira GA; Sultan AA; Bhanot P; Nussenzweig V; Nardin E
    J Immunol; 2002 Dec; 169(12):6681-5. PubMed ID: 12471098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum.
    Holder AA; Lockyer MJ; Hardy GW
    Parasitology; 1988 Dec; 97 ( Pt 3)():373-82. PubMed ID: 2464153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmodium berghei: cloning of the circumsporozoite protein gene.
    Weber JL; Egan JE; Lyon JA; Wirtz RA; Charoenvit Y; Maloy WL; Hockmeyer WT
    Exp Parasitol; 1987 Jun; 63(3):295-300. PubMed ID: 3556207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ballou WR; Ruebush TK; Nardin EH; Chulay JD; Majarian WR; Young JF; Wasserman GF; Bathurst I
    Am J Trop Med Hyg; 1989 May; 40(5):455-64. PubMed ID: 2658634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural localization of Plasmodium falciparum circumsporozoite protein in newly invaded hepatoma cells.
    Aley SB; Atkinson CT; Aikawa M; Maloy WL; Hollingdale MR
    J Parasitol; 1987 Dec; 73(6):1241-5. PubMed ID: 2830392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).
    Webster HK; Boudreau EF; Pang LW; Permpanich B; Sookto P; Wirtz RA
    J Clin Microbiol; 1987 Jun; 25(6):1002-8. PubMed ID: 2439533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?
    Schofield L
    Bull World Health Organ; 1990; 68 Suppl(Suppl):66-73. PubMed ID: 1709835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
    Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria.
    Yadava A; Nurmukhambetova S; Pichugin AV; Lumsden JM
    J Infect Dis; 2012 May; 205(9):1456-63. PubMed ID: 22457289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum.
    Kumar S; Miller LH; Quakyi IA; Keister DB; Houghten RA; Maloy WL; Moss B; Berzofsky JA; Good MF
    Nature; 1988 Jul; 334(6179):258-60. PubMed ID: 2456467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity of the repetitive and nonrepetitive peptide regions of the divergent CS protein of Plasmodium knowlesi.
    Sharma S; Gwadz RW; Schlesinger DH; Godson GN
    J Immunol; 1986 Jul; 137(1):357-61. PubMed ID: 3086454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera.
    do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR
    Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Plasmodium sporozoite neutralization assay (TSNA).
    Kumar KA; Oliveira GA; Edelman R; Nardin E; Nussenzweig V
    J Immunol Methods; 2004 Sep; 292(1-2):157-64. PubMed ID: 15350520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.